0
polski english
Sign in Register
phone Help-contact

arch42

EN_01446596_7102
arch42
  • 30,00 EUR

    Making print for private purpose, storage in computer memory, no distribution rights.

  • 40,00 EUR

    Strictly for editorial, single use on a personal (nonprofit) web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.

  • 75,00 EUR

    Strictly for editorial, single use on a commercial web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.

  • 90,00 EUR

    Strictly for editorial, single use, inside of newspaper, magazine, book (including digital version), one edition, one single country. Not for resale.

Gross prices
Contact us to calculate price for another use. Prices only for online sales.
Internet +100%
Albert Bourla, DVM, Ph.D., Chief Executive Officer of Pfizer appears before the Senate Committee on Finance for a hearing on prescription drug pricing on Capitol Hill in Washington, DC, USA, February 26, 2019. - A Covid-19 vaccine being developed by Pfizer and Germany's BioNTech has been found to be more than 90 per cent effective, in a breakthrough that could make the shot available for use by the end of the year if drug authorities give it the green light. Photo by Chris Kleponis/CNP/ABACAPRESS.COM
More >><< Less
arch42
2019-02-26
Kleponis Chris/CNP/ABACA/Abaca/East News
Abaca
Kleponis Chris/CNP/ABACA
672315_001
1,74MB
25cm x 21cm by 300dpi
2019, 26, 90, A, ABACA, ABACAPRESS, ALBERT, AND, APPEARS, AUTHORITIES, AVAILABLE, BE, BEEN, BEFORE, BEING, BIONTECH, BOURLA, BREAKTHROUGH, BY, CAPITOL, CENT, CHIEF, CHRIS, CNP, COMMITTEE, COULD, COVID-19, D, DC, DEVELOPED, DRUG, DVM, EFFECTIVE, END, EXECUTIVE, FEBRUARY, FINANCE, FOR, FOUND, GERMANY, GIVE, GREEN, HAS, HEARING, HILL, IF, IN, IT, KLEPONIS, LIGHT, MAKE, MORE, OF, OFFICER, ON, PER, PFIZER, PH, PRESCRIPTION, PRICING, SENATE, SHOT, THAN, THAT, THE, TO, USA, USE, VACCINE, WASHINGTON, YEAR,